Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections
Description
Infections by bacteria, general or unspecified. MeSH
Hierarchy View
Subtype Terms (12)
Bacteremia
68 drugs (50 approved, 18 experimental)
Central Nervous System Bacterial Infections
2 approved drugs
Endocarditis, Bacterial
12 drugs (11 approved, 1 experimental)
Eye Infections, Bacterial
9 drugs (8 approved, 1 experimental)
Fournier Gangrene
4 drugs (3 approved, 1 experimental)
Gram-Negative Bacterial Infections
19 drugs (13 approved, 6 experimental)
Gram-Positive Bacterial Infections
30 drugs (23 approved, 7 experimental)
Pneumonia, Bacterial
60 drugs (45 approved, 15 experimental)
Sexually Transmitted Diseases, Bacterial
1 approved drug
Skin Diseases, Bacterial
41 drugs (32 approved, 9 experimental)
Vaginosis, Bacterial
70 drugs (31 approved, 39 experimental)
Approved Indicated Drugs (68)
Phase 4 Indicated Drugs (53)
Phase 3 Indicated Drugs (50)
DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine (Pediarix)
haemophilus influenzae type b conjugate vaccine (HibTITER)
hepatitis b vaccine (recombinant) (Recombivax)
hexavalent pneumococcal polysaccharide vaccine
immune globulin (human) (Gamastan)
measles, mumps, and rubella vaccine (MMR)
measles, mumps, rubella, varicella vaccine (ProQuad)
Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi)
Monovalent group C meningococcal vaccine (Menomune-C)
Phase 2 Indicated Drugs (20)
Phase 1 Indicated Drugs (46)
Other Experimental Indicated Drugs (26)
Organization Involved with Phase 4 Indications (66)
Katholieke Universiteit Leuven
Moorgreen Hospital, Southampton
National Cancer Institute, Egypt
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
National University of Ireland
The Baruch Padeh Medical Center, Poriya
Universidad Autonoma de Barcelona
Universidad Complutense de Madrid
Organization Involved with Phase 3 Indications (44)
Institute of Tropical Medicine, Belgium
Interactive Research and Development
Organization Involved with Phase 2 Indications (31)
Organization Involved with Phase 1 Indications (43)
China Academy of Chinese Medical Sciences
German Center for Infection Research
Hammersmith Medicines Research
Hoosier Cancer Research Network
Institut National de la Santé Et de la Recherche Médicale, France
International Pharmaceutical Research Center, Jordan
Organization Involved with Other Experimental Indications (19)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
